Does Mounjaro Cause Cancer in Humans? What the Evidence Says (October 2026)

01 · The core answer

Does Mounjaro cause cancer in humans?

There is no proof that Mounjaro causes cancer in humans. The product information says that in rodent studies tirzepatide caused thyroid C-cell tumours, that it is not known whether this applies to humans, and that no increase has been shown in human trials.¹

It does not say the risk is proven to be zero. It says an animal signal exists, that human trials have not reproduced it, and that the question is still treated with caution.

For questions about any other type of cancer, your prescriber is the right person to advise, because they can look at your own history. If you want a broader overview, our complete UK guide to Mounjaro and cancer covers the wider picture.

02 · Your situation

Is this relevant to me?

It is most relevant if you or a close relative have had medullary thyroid cancer, or if you have the inherited condition MEN 2. In that case, tell your prescriber before you start. They will weigh it in your assessment.¹

If you have no such history, the precaution is still worth knowing about, but it does not change how most people are assessed. Routine thyroid monitoring is not required for most people.¹ That tells you how regulators and prescribers weigh the risk in practice: as a screening question at the start, not as a reason for regular scans or blood tests.

First, answer the health questionnaire fully and honestly, including family history. Second, if something is unclear, ask the prescriber a direct question. A consultation with us is free, and every order is reviewed by a GPhC-registered prescriber.

Related guides: Does mounjaro cause aggression and Can mounjaro cause sleepless nights and Can mounjaro cause raynaud's and Can mounjaro cause breathlessness.

03 · The rodent finding

What the rodent studies found

In rodent studies, tirzepatide caused thyroid C-cell tumours.¹ C-cells are a type of cell in the thyroid gland, and the cancer that arises from them is called medullary thyroid cancer. That is why this specific cancer is named in the precaution, and why other cancers are not part of it.

A signal in rodents is a reason to look carefully in people, not a result about people. The product information records the next step plainly: it is not known whether this applies to humans, and no increase has been shown in human trials.¹

The honest position is that the finding is unresolved in humans, the human evidence so far has not shown an increase, and a sensible precaution is built into assessment.

04 · The black box warning

What is the black box warning on Mounjaro?

In UK product information the same issue appears as the thyroid statement: tirzepatide caused thyroid C-cell tumours in rodents, it is not known whether this applies to humans, and no increase has been shown in human trials.¹

So the label does not mean that Mounjaro is known to cause cancer in people. The practical step is to tell your prescriber about medullary thyroid cancer or MEN 2 in you or a close relative.

If you read a headline that makes the warning sound like a confirmed human cancer link, check what it actually cites. Headlines often blur the difference between a finding in rodents and a result in people.

05 · Who should tell their prescriber

Who needs to flag thyroid history

You should tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2.¹ If you do not know your family history, ask a relative before the consultation rather than guessing.

What happens next is an individual judgement. The prescriber weighs the history in your assessment, and the outcome may be going ahead, taking extra care, or recommending against treatment.

Beyond thyroid history, Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.

06 · Serious side effects

What are the serious side effects of Mounjaro?

Serious side effects are uncommon but need urgent attention.¹

Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis. Seek immediate medical help too for pain in the upper right abdomen, fever or yellowing of skin or eyes, which could be gallbladder problems. Seek immediate medical help for signs of a severe allergic reaction, such as swelling of the face or throat and difficulty breathing.¹³

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion). Your prescriber may need to adjust those medicines.¹³

Any suspected side effect can be reported through the MHRA Yellow Card scheme.¹⁹

07 · Long-term effects

What are the long-term effects of Mounjaro?

In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they are why prescribers talk about weight management as health management rather than appearance.

For organs people worry about, the information is reassuring but not absolute. Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment. The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and contact your clinical team if you cannot keep fluids down. People with severe impairment need individual prescriber assessment.¹

08 · Mounjaro versus other injections

Which is safer: Mounjaro, Ozempic or Wegovy?

Mounjaro (tirzepatide) activates GIP and GLP-1 receptors, while Wegovy and Ozempic contain semaglutide, a single-action GLP-1 medicine.¹ All are licensed, prescription-only treatments, and all carry their own product information that your prescriber reads against your history. Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label.

The direct tirzepatide versus semaglutide comparison, SURMOUNT-5, looks at weight-loss outcomes, not cancer.¹⁵

The better question is which is more suitable for you. That depends on your health history, other medicines, what you have tolerated before and what you are aiming for. A prescriber can compare these properly in a consultation.

09 · What to avoid

What should I avoid while taking Mounjaro?

Avoid taking it if you fall into the groups in the product information: allergy to tirzepatide or its ingredients, pregnancy or trying to conceive.¹ Avoid hiding relevant history from your prescriber, particularly thyroid cancer history in the family.

Avoid buying from sellers who offer to supply without a consultation or prescription. Mounjaro is prescription-only, and counterfeit medicine alerts exist for a reason.⁷

Avoid ignoring dehydration. If vomiting or diarrhoea means you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away. And avoid treating a new symptom as automatically caused by the medicine, or automatically unrelated. Raise it with your prescriber and report it via Yellow Card.¹⁹

10 · News, rules and rumours

The latest news and new rules

On access, Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

On safety news, treat a headline as a prompt to check the source, not as a conclusion. A story about an animal study, a single case report or a political comment is not evidence that Mounjaro causes cancer in humans. If a story is about a regulator's decision, look for the regulator's own statement.

11 · How to judge cancer claims

How to judge a cancer claim about Mounjaro

Start by asking what kind of evidence is being described. A rodent finding, a human trial result, a regulator's review and a social media post are very different things. Only the first is established for Mounjaro and thyroid C-cells, and even the product information says it is not known whether it applies to humans.¹

Next, ask whether the claim is specific. The product information names medullary thyroid cancer and MEN 2.

Finally, if you have a personal reason to worry, take it to a clinician. Online reading cannot weigh your family history, and your prescriber can. If a symptom worries you after starting, report it through the Yellow Card scheme as well as telling your prescriber.¹⁹

12 · Mood and other worries

Other safety questions people ask

People who worry about cancer often have other safety questions at the same time. Mood is a common one. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts, and the EMA's safety committee concluded that the evidence does not support a causal link, while the MHRA keeps this under continuous review.¹⁷ Even so, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. This page is information, not a substitute for medical advice.